Kommerzielle Forschung im Europäischen Gesundheitsdatenraum (EHDS)

This book provides guidance in one of the most dynamic areas of European health regulation: the use of health data for commercial purposes. It examines whether, and to what extent, companies may access and use data from the European Health Data Space for drug development, innovation, and strategic research. The analysis focuses on the interaction between secondary use, data protection, professional secrecy, trade secrets, and fundamental rights, and on the resulting regulatory tensions. It develops a structured interpretation of the legal framework and identifies targeted needs for reform. It is aimed at academia, practitioners, policymakers, and regulators.